Correlation Between Fidelity Freedom and Novo Nordisk
Can any of the company-specific risk be diversified away by investing in both Fidelity Freedom and Novo Nordisk at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fidelity Freedom and Novo Nordisk into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Fidelity Freedom Blend and Novo Nordisk AS, you can compare the effects of market volatilities on Fidelity Freedom and Novo Nordisk and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fidelity Freedom with a short position of Novo Nordisk. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fidelity Freedom and Novo Nordisk.
Diversification Opportunities for Fidelity Freedom and Novo Nordisk
0.61 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Fidelity and Novo is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding Fidelity Freedom Blend and Novo Nordisk AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Novo Nordisk AS and Fidelity Freedom is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fidelity Freedom Blend are associated (or correlated) with Novo Nordisk. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Novo Nordisk AS has no effect on the direction of Fidelity Freedom i.e., Fidelity Freedom and Novo Nordisk go up and down completely randomly.
Pair Corralation between Fidelity Freedom and Novo Nordisk
Assuming the 90 days horizon Fidelity Freedom is expected to generate 4.01 times less return on investment than Novo Nordisk. But when comparing it to its historical volatility, Fidelity Freedom Blend is 5.44 times less risky than Novo Nordisk. It trades about 0.3 of its potential returns per unit of risk. Novo Nordisk AS is currently generating about 0.22 of returns per unit of risk over similar time horizon. If you would invest 12,390 in Novo Nordisk AS on February 15, 2024 and sell it today you would earn a total of 981.00 from holding Novo Nordisk AS or generate 7.92% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 95.65% |
Values | Daily Returns |
Fidelity Freedom Blend vs. Novo Nordisk AS
Performance |
Timeline |
Fidelity Freedom Blend |
Novo Nordisk AS |
Fidelity Freedom and Novo Nordisk Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Fidelity Freedom and Novo Nordisk
The main advantage of trading using opposite Fidelity Freedom and Novo Nordisk positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fidelity Freedom position performs unexpectedly, Novo Nordisk can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novo Nordisk will offset losses from the drop in Novo Nordisk's long position.The idea behind Fidelity Freedom Blend and Novo Nordisk AS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.Novo Nordisk vs. Regeneron Pharmaceuticals | Novo Nordisk vs. Crispr Therapeutics AG | Novo Nordisk vs. Sarepta Therapeutics | Novo Nordisk vs. Intellia Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |